Logo image of CBUS

CIBUS INC (CBUS) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CBUS - US17166A1016 - Common Stock

1.7 USD
-0.05 (-2.86%)
Last: 12/26/2025, 8:00:02 PM
1.66 USD
-0.04 (-2.35%)
After Hours: 12/26/2025, 8:00:02 PM
Fundamental Rating

2

Overall CBUS gets a fundamental rating of 2 out of 10. We evaluated CBUS against 530 industry peers in the Biotechnology industry. Both the profitability and financial health of CBUS have multiple concerns. CBUS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CBUS had negative earnings in the past year.
In the past year CBUS has reported a negative cash flow from operations.
CBUS had negative earnings in each of the past 5 years.
CBUS had a negative operating cash flow in each of the past 5 years.
CBUS Yearly Net Income VS EBIT VS OCF VS FCFCBUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M -200M -250M

1.2 Ratios

Looking at the Return On Assets, with a value of -79.54%, CBUS is doing worse than 67.36% of the companies in the same industry.
Looking at the Return On Equity, with a value of -381.79%, CBUS is doing worse than 74.91% of the companies in the same industry.
Industry RankSector Rank
ROA -79.54%
ROE -381.79%
ROIC N/A
ROA(3y)-65.46%
ROA(5y)-69.14%
ROE(3y)-199.52%
ROE(5y)-185.43%
ROIC(3y)N/A
ROIC(5y)N/A
CBUS Yearly ROA, ROE, ROICCBUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

CBUS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CBUS Yearly Profit, Operating, Gross MarginsCBUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K

More info and screens

2

2. Health

2.1 Basic Checks

CBUS does not have a ROIC to compare to the WACC, probably because it is not profitable.
CBUS has more shares outstanding than it did 1 year ago.
CBUS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CBUS has an improved debt to assets ratio.
CBUS Yearly Shares OutstandingCBUS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CBUS Yearly Total Debt VS Total AssetsCBUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of -3.69, we must say that CBUS is in the distress zone and has some risk of bankruptcy.
CBUS has a Altman-Z score of -3.69. This is comparable to the rest of the industry: CBUS outperforms 42.08% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that CBUS is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.00, CBUS perfoms like the industry average, outperforming 48.49% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -3.69
ROIC/WACCN/A
WACC8.77%
CBUS Yearly LT Debt VS Equity VS FCFCBUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

CBUS has a Current Ratio of 1.78. This is a normal value and indicates that CBUS is financially healthy and should not expect problems in meeting its short term obligations.
CBUS's Current ratio of 1.78 is on the low side compared to the rest of the industry. CBUS is outperformed by 79.25% of its industry peers.
A Quick Ratio of 1.78 indicates that CBUS should not have too much problems paying its short term obligations.
The Quick ratio of CBUS (1.78) is worse than 77.74% of its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.78
CBUS Yearly Current Assets VS Current LiabilitesCBUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

5

3. Growth

3.1 Past

CBUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 82.01%, which is quite impressive.
Looking at the last year, CBUS shows a very strong growth in Revenue. The Revenue has grown by 134.56%.
CBUS shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -10.20% yearly.
EPS 1Y (TTM)82.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-833.33%
Revenue 1Y (TTM)134.56%
Revenue growth 3Y-45.26%
Revenue growth 5Y-10.2%
Sales Q2Q%-63.11%

3.2 Future

CBUS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.85% yearly.
CBUS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 129.07% yearly.
EPS Next Y18.82%
EPS Next 2Y26.54%
EPS Next 3Y17.72%
EPS Next 5Y20.85%
Revenue Next Year0.81%
Revenue Next 2Y45.48%
Revenue Next 3Y136.77%
Revenue Next 5Y129.07%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CBUS Yearly Revenue VS EstimatesCBUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
CBUS Yearly EPS VS EstimatesCBUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -20 -40 -60

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CBUS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CBUS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CBUS Price Earnings VS Forward Price EarningsCBUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CBUS Per share dataCBUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2 -3

4.3 Compensation for Growth

A more expensive valuation may be justified as CBUS's earnings are expected to grow with 17.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.54%
EPS Next 3Y17.72%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CBUS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

CIBUS INC

NASDAQ:CBUS (12/26/2025, 8:00:02 PM)

After market: 1.66 -0.04 (-2.35%)

1.7

-0.05 (-2.86%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-13 2025-11-13/amc
Earnings (Next)03-18 2026-03-18/amc
Inst Owners21.7%
Inst Owner Change-9.65%
Ins Owners30.16%
Ins Owner Change0%
Market Cap92.28M
Revenue(TTM)4.26M
Net Income(TTM)-275.36M
Analysts80
Price Target14.69 (764.12%)
Short Float %3.46%
Short Ratio2.79
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.91%
Min EPS beat(2)-9.92%
Max EPS beat(2)13.74%
EPS beat(4)2
Avg EPS beat(4)24.36%
Min EPS beat(4)-12.97%
Max EPS beat(4)106.57%
EPS beat(8)2
Avg EPS beat(8)-93.21%
EPS beat(12)4
Avg EPS beat(12)-138.57%
EPS beat(16)7
Avg EPS beat(16)-98.59%
Revenue beat(2)0
Avg Revenue beat(2)-15.64%
Min Revenue beat(2)-20.19%
Max Revenue beat(2)-11.09%
Revenue beat(4)2
Avg Revenue beat(4)35.33%
Min Revenue beat(4)-20.19%
Max Revenue beat(4)167.48%
Revenue beat(8)6
Avg Revenue beat(8)64.47%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)7.36%
EPS NY rev (3m)15.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-15.11%
Revenue NY rev (3m)-15.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 19.04
P/FCF N/A
P/OCF N/A
P/B 1.28
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.66
EYN/A
EPS(NY)-1.22
Fwd EYN/A
FCF(TTM)-0.98
FCFYN/A
OCF(TTM)-0.97
OCFYN/A
SpS0.09
BVpS1.33
TBVpS-3.56
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -79.54%
ROE -381.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-65.46%
ROA(5y)-69.14%
ROE(3y)-199.52%
ROE(5y)-185.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 12.15%
Cap/Sales 16.34%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 1.78
Altman-Z -3.69
F-Score5
WACC8.77%
ROIC/WACCN/A
Cap/Depr(3y)67.73%
Cap/Depr(5y)64.06%
Cap/Sales(3y)402.26%
Cap/Sales(5y)243.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-833.33%
EPS Next Y18.82%
EPS Next 2Y26.54%
EPS Next 3Y17.72%
EPS Next 5Y20.85%
Revenue 1Y (TTM)134.56%
Revenue growth 3Y-45.26%
Revenue growth 5Y-10.2%
Sales Q2Q%-63.11%
Revenue Next Year0.81%
Revenue Next 2Y45.48%
Revenue Next 3Y136.77%
Revenue Next 5Y129.07%
EBIT growth 1Y10.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year82.7%
EBIT Next 3Y29.41%
EBIT Next 5Y22.66%
FCF growth 1Y-131.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-136.37%
OCF growth 3YN/A
OCF growth 5YN/A

CIBUS INC / CBUS FAQ

Can you provide the ChartMill fundamental rating for CIBUS INC?

ChartMill assigns a fundamental rating of 2 / 10 to CBUS.


What is the valuation status for CBUS stock?

ChartMill assigns a valuation rating of 0 / 10 to CIBUS INC (CBUS). This can be considered as Overvalued.


Can you provide the profitability details for CIBUS INC?

CIBUS INC (CBUS) has a profitability rating of 0 / 10.


What is the financial health of CIBUS INC (CBUS) stock?

The financial health rating of CIBUS INC (CBUS) is 2 / 10.


Can you provide the expected EPS growth for CBUS stock?

The Earnings per Share (EPS) of CIBUS INC (CBUS) is expected to grow by 18.82% in the next year.